Evidence map›Paper›PMID 35966843›Full record

ArticleFrontiers in medicine2022

Whole genome sequencing of the multidrug-resistant

Marcelo Silva Folhas Damas, Roumayne Lopes Ferreira, Emeline Boni Campanini, Gabriela Guerrera Soares, Leslie Camelo Campos, Pedro Mendes Laprega, Andrea Soares da Costa, Caio César de Melo Freire, André Pitondo-Silva, Louise Teixeira Cerdeira and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Draft genome ofMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Genomic Insights into Emerging Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
  6. Article
  7. Two colistin resistance-producingFrontiers in microbiology · 2024
    Article
  8. Microbiology spectrum · 2023
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marcelo Silva Folhas DamasDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Roumayne Lopes FerreiraDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Emeline Boni CampaniniDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Gabriela Guerrera SoaresDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Leslie Camelo CamposLaboratório Central de Saúde Pública do Tocantins, Palmas, TO, Brazil.
Pedro Mendes LapregaDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Andrea Soares da CostaDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Caio César de Melo FreireDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
André Pitondo-SilvaPrograma de Pós-graduação em Odontologia e Tecnologia Ambiental, Universidade de Ribeirão Preto, Ribeirão Preto, SP, Brazil.
Louise Teixeira CerdeiraDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Anderson Ferreira da CunhaDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Maria-Cristina da Silva PrancheviciusDepartamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Universidade Federal de São Carlos · BRLiverpool School of Tropical Medicine · GBUniversidade de Ribeirão Preto · BRUniversidade do Tocantins · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chryseobacterium indologenes is a non-glucose-fermenting Gram-negative bacillus. This emerging multidrug resistant opportunistic nosocomial pathogen can cause severe infections in neonates and immunocompromised patients. This study aimed to present the first detailed draft genome sequence of a multidrug-resistant

Indexed as

Chryseobacterium indologenesmetabolic featuresmobile genetic elementsneonatal intensive care unitvirulence and resistance geneswhole-genome sequencing

Identifiers

PMID35966843
PMCPMC9366087
OpenAlexW4288077424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.